Asher Biotherapeutics
PrivateLast Round
Series C
Apr 16, 2024
Total Funding Raised
$218.15M
Company Overview
Asher Biotherapeutics is a biotechnology company that develops precisely targeted immunotherapies for cancer and other diseases using a proprietary cis-targeting platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Asher Biotherapeutics Comparables
Compare Asher Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthekine | 91% | |
| Bright Peak Therapeutics | 89% | |
| Inhibrx | 83% | |
Asher Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 16, 2024 | ||||
| Series B | Sep 1, 2021 | ||||
| Series A | Mar 23, 2021 | ||||
| Accelerator | Aug 21, 2019 |
Key People
Founding team and executive leadership
Asher Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series C, Series B |
| RA Capital Management | Series B, Series C |
| Boxer Capital | Series A, Series C, Series B |
| Invus Opportunities | Series A, Series B |
| Logos Capital | Series B |
| Alexandria Venture Investments | Series B |
| Y Combinator | Series A, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2024
$55M round led by RA Capital Management.
- Sep 1, 2021
$108M round led by Wellington Management.
Asher Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Asher Biotherapeutics's valuation, stock price, and market status.